NO2661276T3 - - Google Patents

Info

Publication number
NO2661276T3
NO2661276T3 NO11855190A NO11855190A NO2661276T3 NO 2661276 T3 NO2661276 T3 NO 2661276T3 NO 11855190 A NO11855190 A NO 11855190A NO 11855190 A NO11855190 A NO 11855190A NO 2661276 T3 NO2661276 T3 NO 2661276T3
Authority
NO
Norway
Application number
NO11855190A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46457668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2661276(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2661276T3 publication Critical patent/NO2661276T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
NO11855190A 2011-01-07 2011-12-22 NO2661276T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161430868P 2011-01-07 2011-01-07

Publications (1)

Publication Number Publication Date
NO2661276T3 true NO2661276T3 (es) 2017-12-30

Family

ID=46457668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO11855190A NO2661276T3 (es) 2011-01-07 2011-12-22

Country Status (17)

Country Link
US (3) US20120294844A1 (es)
EP (2) EP2661276B1 (es)
JP (4) JP6444032B2 (es)
BR (1) BR112013017311A2 (es)
CY (1) CY1119427T1 (es)
DK (1) DK2661276T3 (es)
ES (1) ES2641068T3 (es)
HK (1) HK1247553A1 (es)
HR (1) HRP20171483T1 (es)
HU (1) HUE035057T2 (es)
LT (1) LT2661276T (es)
NO (1) NO2661276T3 (es)
PL (1) PL2661276T3 (es)
PT (1) PT2661276T (es)
RS (1) RS56460B1 (es)
SI (1) SI2661276T1 (es)
WO (1) WO2012094163A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101453963B1 (ko) * 2005-03-03 2014-10-22 레반스 테라퓨틱스, 아이엔씨. 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
US20100168023A1 (en) 2008-12-31 2010-07-01 Revance Therapeutics, Inc. Injectable Botulinum Toxin Formulations
MX344583B (es) * 2009-06-25 2016-12-20 Revance Therapeutics Inc Formulaciones de toxina botulinica libres de albumina.
CA2867511A1 (en) * 2012-03-22 2013-09-26 Revance Therapeutics, Inc. Method of treatment of wrinkles using topical chemodenervating agents
JP6955491B2 (ja) * 2015-10-29 2021-10-27 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法
IL308091A (en) 2016-09-13 2023-12-01 Allergan Inc Stabilized Clostridium toxin preparations without protein
JP2020520917A (ja) * 2017-05-18 2020-07-16 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 頸部ジストニアの治療方法
WO2019046311A1 (en) 2017-08-28 2019-03-07 Revance Therapeutics, Inc. TRANSMUCOSAL COMPOSITIONS OF BOTULINUM TOXIN, KITS AND METHODS FOR TREATING BLADDER DISORDERS
US20210321696A1 (en) * 2020-04-20 2021-10-21 First Step Holdings, Llc Covid mask

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286016A (en) * 1979-04-12 1981-08-25 The Drackett Company Pouch bleach
US4797128A (en) 1984-12-10 1989-01-10 Quadrex Hps, Inc. Method of and apparatus for cleaning garments and soft goods contaminated with nuclear, chemical and/or biological contaminants
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5624636A (en) 1994-11-07 1997-04-29 Univ. Of Texas Board Of Regents Hypochlorite based disinfectant for dental impressions
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US6566574B1 (en) 1998-06-30 2003-05-20 Sandia Corporation Formulations for neutralization of chemical and biological toxants
US6417423B1 (en) * 1998-09-15 2002-07-09 Nanoscale Materials, Inc. Reactive nanoparticles as destructive adsorbents for biological and chemical contamination
GB2386246B (en) 2001-11-01 2005-06-29 Marconi Applied Techn Ltd Electron beam tube apparatus
US6706092B2 (en) 2002-04-17 2004-03-16 Alliedsignal Inc. Chemical/Biological decontamination filter
US7582595B1 (en) * 2002-11-06 2009-09-01 Taylor Lawnie H Hypochlorous acid/alkali metal hydoxide-containing products, methods and equipment for removing stains from fabrics
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
US7776292B2 (en) * 2004-01-16 2010-08-17 Cdic, Inc. Method and apparatus for bioweapon decontamination
KR101322433B1 (ko) * 2004-03-03 2013-10-28 레반스 테라퓨틱스, 아이엔씨. 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
JP4730304B2 (ja) * 2004-05-20 2011-07-20 和光純薬工業株式会社 ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法
US20080220021A1 (en) 2005-02-14 2008-09-11 Pankaj Modi Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
KR101453963B1 (ko) * 2005-03-03 2014-10-22 레반스 테라퓨틱스, 아이엔씨. 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
US20070154493A1 (en) * 2005-12-30 2007-07-05 Judy Hattendorf Method of treating skin needing botulinum toxin type a treatment
AU2007230730B2 (en) * 2006-03-24 2013-03-28 Auxilium International Holdings, Inc. Stabilized compositions containing alkaline labile drugs
JP2009534309A (ja) * 2006-03-31 2009-09-24 マサチューセッツ インスティテュート オブ テクノロジー 治療剤の標的化送達のためのシステム
DE102006019447A1 (de) * 2006-04-24 2007-10-25 Dressler, Dirk, Dr. Markierung von Botulinum Toxin
ES2520765T3 (es) * 2007-02-15 2014-11-11 Allergan, Inc. Uso de toxina botulínica para el tratamiento de hiperhidrosis
WO2008118564A2 (en) * 2007-03-06 2008-10-02 Steris Inc. Decontamination unit and process
JP2009001423A (ja) * 2007-05-21 2009-01-08 Life:Kk 感染性廃棄物用回収袋又は容器および感染性廃棄物処理方法
WO2009042165A2 (en) * 2007-09-25 2009-04-02 Thomas Jefferson University Mutant botulinum neurotoxin serotype a polypeptide and uses thereof
US20090148342A1 (en) * 2007-10-29 2009-06-11 Bromberg Steven E Hypochlorite Technology
US20090250626A1 (en) * 2008-04-04 2009-10-08 Hexatech, Inc. Liquid sanitization device
US20100168023A1 (en) * 2008-12-31 2010-07-01 Revance Therapeutics, Inc. Injectable Botulinum Toxin Formulations
MX344583B (es) 2009-06-25 2016-12-20 Revance Therapeutics Inc Formulaciones de toxina botulinica libres de albumina.

Also Published As

Publication number Publication date
EP2661276A4 (en) 2014-09-03
JP2014502969A (ja) 2014-02-06
HUE035057T2 (en) 2018-05-02
RS56460B1 (sr) 2018-01-31
JP2017025083A (ja) 2017-02-02
JP6605420B2 (ja) 2019-11-13
EP2661276A1 (en) 2013-11-13
WO2012094163A1 (en) 2012-07-12
DK2661276T3 (en) 2017-10-02
JP6444032B2 (ja) 2018-12-26
US20210189326A1 (en) 2021-06-24
ES2641068T3 (es) 2017-11-07
JP2020172519A (ja) 2020-10-22
EP2661276B1 (en) 2017-08-02
HRP20171483T1 (hr) 2017-12-01
EP3248614A1 (en) 2017-11-29
US20140154237A1 (en) 2014-06-05
SI2661276T1 (sl) 2017-12-29
BR112013017311A2 (pt) 2016-10-04
JP2018188447A (ja) 2018-11-29
PT2661276T (pt) 2017-10-06
PL2661276T3 (pl) 2018-03-30
US20120294844A1 (en) 2012-11-22
HK1247553A1 (zh) 2018-09-28
LT2661276T (lt) 2017-12-11
CY1119427T1 (el) 2018-03-07

Similar Documents

Publication Publication Date Title
BR112013022641A2 (es)
AP3853A (es)
BR112013031251A2 (es)
BR112013027245A2 (es)
BR112013024383A2 (es)
BR112013026905A2 (es)
BR112013023185A2 (es)
BR112013022995A2 (es)
BR112013017670A2 (es)
BR112013026744A2 (es)
BR112013023927A2 (es)
BR112013027830A2 (es)
BR112013024365A2 (es)
BR112013028733A2 (es)
BR112013027121A2 (es)
BR112013027452A2 (es)
AP2016009466A0 (es)
BR112013031556A2 (es)
BR112013026790A2 (es)
BR112013024588A2 (es)
BR112013032377A2 (es)
BR112013032380A2 (es)
BR112013032366A2 (es)
BR112013018949A2 (es)
BR112013026895A2 (es)